Synthesis of putative metabolites and investigation of the metabolic fate of gliclazide, [1-(3-azabicyclo(3,3,0)oct-3-yl)-3-(4-methylphenylsulfonyl) urea], in diabetic patients.
Synthesis of postulated hydroxylated metabolites of gliclazide is described together with their detailed structural analysis using 1H-NMR, two-dimensional 1H-NMR, and MS to characterize the products. Metabolism of gliclazide has been investigated in the urine of nine patients of different ethnic origins receiving gliclazide therapy for the treatment of diabetes. Urine extracts were analyzed by GC/MS to quantify and identify the metabolites excreted in urine and the metabolites compared with the synthesized products. Metabolic profiles in all diabetic patients were very similar and comparable with those reported for healthy human volunteers. In addition to the expected metabolites arising from oxidation of the 4-methylphenyl ring, four isomeric hydroxylated products of the azabicyclooctyl ring were identified and the structure of a fifth isomer postulated.
Taylor
A R
AR
Servier Research and Development Ltd., Fulmer, Slough, UK.
Brownsill
R D
RD
Grandon
H
H
Lefoulon
F
F
Petit
A
A
Luijten
W
W
Kopelman
P G
PG
Walther
B
B
D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000378:metabolism*; D005006:Ethnicity; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D005907:Gliclazide / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D015394:Molecular Structure
D007004:Hypoglycemic Agents; D005907:Gliclazide